Clinical trial
Genetic Diagnosis and the Response to Recombinant Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
NCT05070234 is registered in ClinicalTrials.gov with Chunxiu Gong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Diagnosis and the Response to Recombinant Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
- Lead sponsor
- Chunxiu Gong
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 11, 2021
- Completion date
- August 30, 2022
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
genetic diseases, inborn, silver-russell syndrome, small for gestational age infant